What You Should Know:
- Eko, a digital health company applying machine learning in the fight against heart and lung disease, today announced that it was awarded a $2.7M Small Business Innovation Research (SBIR) Direct Phase II grant by the National Institutes of Health’s (NIH) Department of Health and Human Services (HHS).
- The grant will fund the development of a machine learning algorithm that detects and stratifies pulmonary hypertension (PH) using phonocardiogram (PCG) and
Read More
Eko DUO
Eko Launches Next Generation DUO ECG + Digital Stethoscope for Frontline Clinicians
What You Should Know:
- Eko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management.
- DUO is a pocket-sized cardiac examination system for clinicians used to detect early signs of heart disease and facilitate timely care for patients in and out of the clinic.
Read More
3M and Eko Launches 3M Littmann® CORE Digital Stethoscope for Clinicians
What You Should Know:
- 3M and Eko team up to launch 3M Littmann® CORE Digital
Stethoscope to deliver a game-changing tool for clinicians as they assess,
diagnose, and monitor their patients.
- The new 3M Littmann CORE Digital Stethoscope offers
clinicians access to both analog and digital auscultation options and connects
to Eko’s software and AI algorithms* to help clinicians better interpret sounds
and detect heart murmurs.
3M™ Littmann® Stethoscopes and Eko, today announced the
Read More
Eko Launches AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
What You Should Know:
Eko launches first AI-Powered telehealth platform for virtual
pulmonary and cardiac exams, providing clinicians with in-person level exam capabilities
during video visits.
Already deployed by more than 200 health systems for telehealth, platform goes beyond standard video conferencing to facilitate stethoscope audio, ECG live-streaming, and FDA-cleared identification of atrial fibrillation (AFib) and heart murmurs.
Eko today
announced Eko Telehealth, an
Read More
FDA Clears Eko’s AFib, Heart Murmur Detection Algorithms for AI-Powered Stethoscope
- StartX company, Eko, announced today that the FDA has cleared Eko’s AFib and heart murmur detection algorithms, making it the first AI-powered stethoscope to screen for serious heart conditions. - Eko’s algorithms alert clinicians to the presence of heart murmurs and atrial fibrillation (AFib) during the physical exam, converting the classic stethoscope into a powerful early detection tool. Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease,
Read More
FDA Breakthrough Status Granted for Heart Failure Algorithm by Eko
- Eko announced the FDA has granted “breakthrough status” for an algorithm that could provide an easily accessible screening test for heart failure during routine physical exams.- This designation is awarded to novel innovations that demonstrate the potential to address unmet medical needs for life-threatening or irreversibly debilitating diseases. - Heart failure is often left untreated until it’s too late due to costs, inaccessibility to echocardiogram testing, or misdiagnosis. With nearly six
Read More
Heart Failure is Detectable at Point of Care Using ECG-Enabled Stethoscope, Mayo Clinic and Eko Finds
- Eko and Mayo Clinic announced they have proven that heart failure is detectable during routine physical exams, further validating the Eko DUO digital stethoscopes as a heart failure screening tool. - Today’s news marks the first time that a point of care device with a single lead ECG combined with an AI algorithm identified low ejection fraction in patients.- The results of these findings, which are comparable to research published earlier this year in NatureMedicine, were presented over the
Read More
Eko Raises $20M to Expand Machine Learning Platform for Cardiac Monitoring/Analysis
- AI-driven digital health startup Eko raises $20M led by ARTIS Ventures with participation from 3M and Mayo Clinic.
- Funding will be used to accelerate research and development (R&D) and commercialization of Eko’s machine learning platform for cardiac screening/analysis.
- Eko’s cardiac monitor combines digital stethoscope and ECG technology both for in-clinic and at-home monitoring, which enables patients to seamlessly and consistently send cardiac data to their
Read More
Eko Unveils Investigational Aortic Stenosis (AS) Detection Algorithm
Eko, a Berkeley-based digital health company applying artificial intelligence and machine learning in the fight against heart disease unveiled an investigational Aortic Stenosis (AS) detection algorithm at the American Society of Echocardiography (ASE) 2019 Scientific Sessions aimed to assist healthcare providers in the early detection of clinically significant AS. The algorithm represents a major step forward toward Eko’s mission to empower healthcare providers with tools to more accurately
Read More
Northwestern Medicine and Eko Launches AI Algorithms Heart Murmurs Study
Northwestern Medicine and Eko launches a new clinical study to validate algorithms that help providers more accurately screen for valvular heart disease with a digital stethoscopeToday Northwestern Medicine Bluhm Cardiovascular Institute and Eko have announced a partnership pioneering the use of artificial intelligence (AI) for cardiac screening in a new study of Eko’s cardiac monitoring platform. The study aims to demonstrate that Eko’s digital stethoscopes and AI algorithms can interpret heart
Read More
